1. Home
  2. SPRY vs LGIH Comparison

SPRY vs LGIH Comparison

Compare SPRY & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.72

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$41.81

Market Cap

984.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRY
LGIH
Founded
2015
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
829.3M
984.3M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
SPRY
LGIH
Price
$8.72
$41.81
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$40.00
$75.90
AVG Volume (30 Days)
959.2K
393.6K
Earning Date
06-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.12
Revenue
$84,278,000.00
$1,705,504,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$91.00
$14.33
P/E Ratio
N/A
$13.37
Revenue Growth
N/A
N/A
52 Week Low
$6.66
$39.70
52 Week High
$18.63
$74.84

Technical Indicators

Market Signals
Indicator
SPRY
LGIH
Relative Strength Index (RSI) 41.71 28.72
Support Level $8.61 $41.82
Resistance Level $10.44 $55.90
Average True Range (ATR) 0.46 1.88
MACD -0.02 -1.00
Stochastic Oscillator 40.74 16.85

Price Performance

Historical Comparison
SPRY
LGIH

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

Share on Social Networks: